Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease-Reference-Cited by-同舟云学术

Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease

Published:2021-12-07 Issue: Volume: Page:
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Scholz Stefan,Schwarz Magdalena^ORCID,Beck Ekkehard,Meszaros Kinga,Schneider Melanie,Ultsch Bernhard,Greiner Wolfgang

Funder

GlaxoSmithKline Biologicals SA

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-021-00573-w.pdf

Reference63 articles.

1. Nadel S, Ninis N. Invasive meningococcal disease in the vaccine era. Front Pediatr. 2018;6:321. https://doi.org/10.3389/fped.2018.00321.

2. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853–61. https://doi.org/10.1016/s1473-3099(10)70251-6.

3. Booy R, Gentile A, Nissen M, Whelan J, Abitbol V. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Hum Vaccin Immunother. 2019;15(2):470–80. https://doi.org/10.1080/21645515.2018.1532248.

4. Robert Koch Institut (RKI). Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2019. 2020. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuecher/2019 Accessed May 2021.

5. Wang B, Clarke M, Thomas N, Howell S, Afzali HH, Marshall H. The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children. Pediatr Infect Dis J. 2014;33(3):316–8. https://doi.org/10.1097/inf.0000000000000043.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France;PharmacoEconomics - Open;2024-05-23

2. Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany;Infectious Diseases and Therapy;2024-04

3. SARS-CoV-2 vaccination may improve anxious, insomnia and depressive symptoms among Chinese population aged 18–75 years during the COVID-19 pandemic;Scientific Reports;2023-12-12

4. Meningococcal Disease in the Post–COVID-19 Era: A Time to Prepare;Infectious Diseases and Therapy;2023-12

5. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?;Vaccines;2023-05-04